![]() |
Lung Cancer |
Free Subscription
3 AJR Am J Roentgenol |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Lung Cancer is free of charge.
Beyond the AJR: Adherence to Annual Lung Cancer Screening and Rates of Cancer
Diagnosis.
AJR Am J Roentgenol. 2025 Apr 23. doi: 10.2214/AJR.25.33107.
PubMed
Lung-RADS: A Powerful Tool in the Optimization of Lung Cancer Screening.
AJR Am J Roentgenol. 2025 Apr 23. doi: 10.2214/AJR.25.33108.
PubMed
Practical Utilization of Artificial Intelligence Algorithms for Low-Dose Lung
Cancer Screening CT-Finding the Sweet Spot.
AJR Am J Roentgenol. 2025 Apr 23. doi: 10.2214/AJR.25.33119.
PubMed
Laminin-gamma2-NR6A1 Fusion Protein Promotes Metastatic Potential in Non-Small-Cell
Lung Carcinoma Cells without Epidermal Growth Factor Receptor Mutation.
Am J Pathol. 2025 Apr 17:S0002-9440(25)00113.
PubMed
Abstract available
Prognostic Benefit of Segmentectomy for Patients with Low Muscle Mass in
Early-Stage Lung Cancer.
Ann Surg Oncol. 2025 Apr 24. doi: 10.1245/s10434-024-16384.
PubMed
Abstract available
Feasibility of Lung Cancer Screening in Europe: A Pro/con Debate.
Arch Bronconeumol. 2025 Apr 2:S0300-2896(25)00120.
PubMed
Pretreatment plasma sCD14 as a prognostic indicator in advanced non-small cell
lung cancer patients undergoing immunotherapy.
BMC Cancer. 2025;25:763.
PubMed
Abstract available
Abnormal phosphorylation of human LRH1 at Ser510 predicts poor prognosis and
promotes cell viability in lung squamous cell carcinoma.
BMC Cancer. 2025;25:764.
PubMed
Abstract available
Bronchial arterial chemoembolization/infusion combined with iodine-125
brachytherapy in advanced non-small cell lung cancer: a promising salvage therapy
after standard treatment failure.
BMC Cancer. 2025;25:750.
PubMed
Abstract available
Genomic and clinical characterization of HER2 exon 20 mutations in non-small cell
lung cancer: insights from a multicenter study in South China.
BMC Cancer. 2025;25:752.
PubMed
Abstract available
Combining network pharmacology and experimental verification to explore the
inhibitory effects of Deoxyelephantopin (DET) Against Non-Small Cell Lung Cancer
(NSCLC).
BMC Cancer. 2025;25:738.
PubMed
Abstract available
Potential profile analysis of financial toxicity and its related factors among
lung cancer patients.
BMC Cancer. 2025;25:740.
PubMed
Abstract available
Ovarian juvenile granulosa cell tumor: A report from the International Ovarian
and Testicular Stromal Tumor and International Pleuropulmonary Blastoma/DICER1
Registries.
Cancer. 2025;131:e35862.
PubMed
Abstract available
Coronary Artery Calcification Identified on Lung Cancer Screening CT Scans: A
Scoping Review.
Chest. 2025 Apr 18:S0012-3692(25)00437-4. doi: 10.1016/j.chest.2025.
PubMed
Abstract available
Leveraging Longitudinal Patient-Reported Outcomes Trajectories to Predict
Survival in Non-Small-Cell Lung Cancer.
Clin Cancer Res. 2025 Apr 24. doi: 10.1158/1078-0432.CCR-25-0292.
PubMed
Abstract available
Post-operative hypofractionated stereotactic radiotherapy for brain metastases
from lung and breast cancer in patients without prior WBRT: a retrospective dose
escalation study.
Clin Exp Metastasis. 2025;42:27.
PubMed
Abstract available
The Toxicity Profile of Pemetrexed in Non-Small Cell Lung Cancer Patients With
Moderate Renal Impairment: A Retrospective Cohort Study.
Clin Lung Cancer. 2025 Mar 26:S1525-7304(25)00056.
PubMed
Abstract available
Validation of the 9th Tumor, Node, and Metastasis Staging System for Patients
with Surgically Resected Non-Small Cell Lung Cancer.
Eur J Cancer. 2025;222:115436.
PubMed
Abstract available
Added prognostic value of circulating tumor cell numbers in CSF of patients with
leptomeningeal metastasis from epithelial tumors.
Eur J Cancer. 2025;220:115377.
PubMed
Abstract available
Patterns of disease dissemination and survival in patients with synchronous and
metachronous metastatic pancreatic adenocarcinoma: Nationwide population-based
study.
Eur J Cancer. 2025;220:115385.
PubMed
Abstract available
Evaluation of plasma alpha-1-antichymotrypsin as a marker for pulmonary Kaposi
sarcoma.
Int J Cancer. 2025 Jan 30. doi: 10.1002/ijc.35351.
PubMed
Abstract available
Development and validation of a transcription factor regulatory network-based
signature for individualized prognostic risk in lung adenocarcinoma.
Int J Cancer. 2025;156:2440-2451.
PubMed
Abstract available
Management strategies for primary lung carcinosarcoma: a case study and
comprehensive literature review.
J Cancer Res Clin Oncol. 2025;151:147.
PubMed
Abstract available
High-dose versus standard dose twice-daily thoracic radiotherapy in limited stage
small-cell lung cancer: final survival data, long-term toxicity and relapse
patterns in a randomised, open-label, phase II trial.
J Thorac Oncol. 2025 Apr 19:S1556-0864(25)00696.
PubMed
Abstract available
Surveillance with [(18)F]FDG PET/CT of stage I-III lung cancer patients after
completion of curative treatment (SUPE_R): a randomized controlled trial.
J Thorac Oncol. 2025 Apr 19:S1556-0864(25)00693.
PubMed
Abstract available
Predictors and Uptake of Lung Cancer Screening in the US: An Integrative
Literature Review.
Lung Cancer. 2025;203:108529.
PubMed
Abstract available
Atezolizumab with carboplatin plus nab-paclitaxel combination therapy for
advanced nonsquamous non-small cell lung cancer with impaired renal function: A
multicenter, single-arm phase 2 trial (RESTART, LOGiK 2002).
Lung Cancer. 2025;203:108543.
PubMed
Abstract available
Osimertinib vs. Afatinib in 1L therapy of atypical EGFR-mutated metastatic
non-small cell lung cancer (mNSCLC): A multi-institution, real-world survival
analysis.
Lung Cancer. 2025;203:108551.
PubMed
Abstract available
Real-world frontline treatments in patients with advanced non-small-cell lung
cancer harboring epidermal growth factor receptor exon 20 insertions and adjusted
comparisons versus amivantamab plus chemotherapy from the PAPILLON study.
Lung Cancer. 2025;203:108548.
PubMed
Abstract available
Tumor-Infiltrating Clonal Hematopoiesis.
N Engl J Med. 2025;392:1594-1608.
PubMed
Abstract available
The coagulation and tumor system are directly linked through the proteolysis and
activation of epidermal growth factor receptor by thrombin.
Oncogene. 2025;44:1153-1166.
PubMed
Abstract available
Size-segregated analysis of PAHs in Urban air: Source apportionment and health
risk assessment in an Urban canal-adjacent environment.
PLoS One. 2025;20:e0320405.
PubMed
Abstract available
Future risk projection to engage 'near-miss' individuals in lung cancer screening
eligibility: an analysis of ILST data.
Thorax. 2025 Apr 24:thorax-2024-222098. doi: 10.1136/thorax-2024-222098.
PubMed
Abstract available
Thank you for your interest in scientific medicine.